Clinical Trials Logo

Clinical Trial Summary

The impact of breastfeeding on the infant microbiome in vaginally and Cesarean delivered offspring from obese and normal weight mothers.


Clinical Trial Description

Design: Normal weight (NW; pre-pregnant BMI <25.0 kg/m2), obese (Ob; pre-pregnant BMI >30.0 kg/m2), gestational diabetes (GDM), Type 2 diabetes (T2D), and Type 1 diabetes mothers during the 3rd trimester (34-36 weeks) of pregnancy that will be followed -along with their respective offspring- through the first 12 months of life will be recruited from the University of Florida (UF) Health Shands Hospital. Stool, saliva, blood, vaginal swab, human milk, urine, body composition and clinical variables will be collected from mother and infant at 34-36 weeks of gestation (mom only), 2-weeks, 2-months, and 1-year at the UF Clinical Research Center. Infant body composition is the primary outcome and will be monitored via anthropometry. Follow-up data points will be collected from electronic health records (EHR) and include but are not limited to wellness visits by 1 month, 2 months, 4 months, 6 months, 9 months, 12 months, 15 months, 18 months, 2 years, 2 ½ years, 3 years, and each year after that until 17.9 years. Planned data analysis includes linear regression using the R statistical program. The primary data analysis will test maternal health status and human milk bioactive components for associations with the infant microbiome and pediatric outcomes collected by clinical visits and EHR. The study team will recruit equal samples of pregnant mothers in each the following groups (n=50 in each group; 1800 total participants): 1) NW vaginal deliveries; 2) NW C-section deliveries; 3) Ob vaginal deliveries 4) Ob C-section deliveries; 5) GDM vaginal deliveries; 6) GDM C-section deliveries; 7) T2D vaginal deliveries; 8) T2D C-section deliveries; 9) T1D vaginal deliveries; 10) T1D C-section deliveries. Stool, saliva, and vaginal swab samples collected from participants may be used for animal studies whereby germ-free mice are inoculated with stool samples to evaluate a causal role of the microbiome in clinically relevant phenotypes (i.e. pediatric obesity). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02843087
Study type Observational
Source University of Florida
Contact Magda Francois
Phone 813-627-9471
Email magdafrancois@ufl.edu
Status Recruiting
Phase
Start date April 28, 2017
Completion date August 2034

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT06111040 - Nurturing Needs Study: Parenting Food Motivated Children N/A
Completed NCT03036696 - The BEACH Interview Study- Pregnant and Breastfeeding Mothers
Completed NCT02959034 - Pediatric Metabolism and Microbiome Repository
Not yet recruiting NCT02484612 - Exercise Intensity and Appetite in Adolescents N/A
Completed NCT02545764 - Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children N/A
Recruiting NCT02426346 - A Scalable Weight Control Intervention for Adolescents Phase 2
Completed NCT01989065 - Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment. N/A
Completed NCT02160847 - Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors N/A
Completed NCT02343588 - A National School-based Health Lifestyles Interventions Among Chinese Children and Adolescents Against Obesity N/A
Completed NCT02375490 - Healthy Start to Increase Physical Activity and Improve Healthy Eating in Early Childcare Centres N/A
Completed NCT01908153 - Taste Reward Processing in Pediatric Obesity
Completed NCT02074332 - Study on Obesity Intervention With Physical Exercise Among Students in Changping District, Beijing N/A
Completed NCT02086851 - Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program. N/A
Completed NCT01146314 - A Family Based Intervention to Reduce the Risk of Type 2 Diabetes in Children N/A
Terminated NCT00846521 - Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity Phase 4
Completed NCT04164277 - FirstStep2Health Intervention N/A
Withdrawn NCT04600648 - Sweet Taste Responsiveness in Relation to Insulin, Leptin and Adiposity Among Obese Treatment Seeking Children N/A
Completed NCT04395430 - A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19 N/A
Completed NCT03139877 - Pediatric Obesity Observational Prospective Trial